Miyako, S.; Matsuda, T.; Koma, Y.-i.; Koide, T.; Sawada, R.; Hasegawa, H.; Yamashita, K.; Harada, H.; Urakawa, N.; Goto, H.;
et al. Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer. Biomedicines 2023, 11, 174.
https://doi.org/10.3390/biomedicines11010174
AMA Style
Miyako S, Matsuda T, Koma Y-i, Koide T, Sawada R, Hasegawa H, Yamashita K, Harada H, Urakawa N, Goto H,
et al. Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer. Biomedicines. 2023; 11(1):174.
https://doi.org/10.3390/biomedicines11010174
Chicago/Turabian Style
Miyako, Shoji, Takeru Matsuda, Yu-ichiro Koma, Takahiro Koide, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Hitoshi Harada, Naoki Urakawa, Hironobu Goto,
and et al. 2023. "Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer" Biomedicines 11, no. 1: 174.
https://doi.org/10.3390/biomedicines11010174
APA Style
Miyako, S., Matsuda, T., Koma, Y.-i., Koide, T., Sawada, R., Hasegawa, H., Yamashita, K., Harada, H., Urakawa, N., Goto, H., Kanaji, S., Oshikiri, T., & Kakeji, Y.
(2023). Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer. Biomedicines, 11(1), 174.
https://doi.org/10.3390/biomedicines11010174
